← All organizations
Biontech
Also known as: Biontech AG | BioNTech Cell & Gene Therapies GmbH | BioNTech Manufacturing GmbH | Biontech RNA Pharmaceuticals GmbH | BioNTech RNA Pharmaceuticals GmbH | Biontech SE | BioNTech SE | BioNTech (Shanghai) Pharmaceuticals Co., Ltd. | BioNTech Small Molecules GmbH | BioNTech US Inc.
Highest phase reached
Phase 3
First clinical trial
Jun 1, 2012First marketed drug
Aug 23, 2021First NDA
Aug 23, 2021Last known activity
Mar 26, 2026
Timeline
2000s
- Jun 1, 2008
Biontech— Founded
2010s
- Apr 1, 2016
4SC AG— Acquired
- May 8, 2019
MabVax Therapeutics, Inc.— Acquired
2020s
- Jan 17, 2020
Neon Therapeutics— Acquired
- Aug 23, 2021
covid-19 vaccine, mrna— NDA Organization
- Aug 23, 2021
covid-19 vaccine, mrna— NDA Secondary Org
- Nov 13, 2024
Biotheus— Acquired
- Jun 12, 2025
CureVac AG— Acquired
Drugs by trial phase (133 distinct, 185 trials)
Phase 3 (9 own, 24 via acquisition)
Phase 2 (32 own, 27 via acquisition)
Phase 1 (20 own, 21 via acquisition)
Indications
Studied for
- Breast Neoplasms
- Carcinoma
- Carcinoma, Ovarian Epithelial
- Carcinoma, Squamous Cell
- Carcinoma, Transitional Cell
- Colorectal Neoplasms
- Communicable Diseases
- Endometrial Neoplasms
- Glioblastoma
- Head and Neck Neoplasms
- Infections
- Kidney Neoplasms
- Melanoma
- Neoplasm Metastasis
- Neoplasms
- Ovarian Neoplasms
- Papilloma
- Penile Neoplasms
- Prostatic Neoplasms
- Respiratory Tract Infections
- RNA Virus Infections
- Small Cell Lung Carcinoma
- Squamous Cell Carcinoma of Head and Neck
- Triple Negative Breast Neoplasms
- Uterine Cervical Neoplasms
- Virus Diseases
Marketed drugs (1)
Subsidiaries (5 direct, 6 total across the full acquisition tree)
Recent trials (50)
- NCT07293351CollaboratorPhase 1/Phase 2Mar 26, 2026
- NCT07221149CollaboratorPhase 2/Phase 3Mar 9, 2026
- NCT07221357CollaboratorPhase 2/Phase 3Mar 4, 2026
- NCT07291076CollaboratorPhase 1/Phase 2Feb 9, 2026
- NCT07297212OfficialPhase 2Jan 31, 2026
- NCT07297212CollaboratorPhase 2Jan 31, 2026
- NCT07297212Lead sponsorPhase 2Jan 31, 2026
- NCT07255404Lead sponsorPhase 2Dec 31, 2025
- NCT07255404OfficialPhase 2Dec 31, 2025
- NCT07255404CollaboratorPhase 2Dec 31, 2025
- NCT07300839Lead sponsorPhase 3Dec 10, 2025
- NCT07173751OfficialPhase 3Oct 30, 2025
- NCT07173751Lead sponsorPhase 3Oct 30, 2025
- NCT07222384Lead sponsorPhase 3Oct 30, 2025
- NCT07111520Lead sponsorPhase 1/Phase 2Sep 22, 2025
Details
- Founded
- Mainz, DE Jun 1, 2008
- First NDA
- Aug 23, 2021
- Last known activity
- Mar 26, 2026